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To explore the role of interleukin-2 (IL-2) in T cell proliferation, and to circumvent the IL-2
deﬁciency autoimmune syndrome of conventional il2 gene deletion, mice were created
to allow conditional il2 gene deletion when treated with the estrogen analog, tamox-
ifen (TAM) as adults. Splenocytes from four different mouse strains, C57Bl/6 wild type
(WT), conventional IL-2(−/−), TAM-treated Cre recombinase-negative (Cre−)/IL2ﬂ/ﬂ, and
Cre recombinase-positive (Cre+)/IL2ﬂ/ﬂ, were activated with anti-CD3 and anti-CD28, and
monitored for CD4+ and CD8+T cell lymphocyte blastogenesis, aerobic glycolysis, BrdU
incorporation into newly synthesized DNA, and CFSE dye dilution to monitor cell division.
IL-2 productionwasmonitored by quantitative ELISA andmultiple additional cytokineswere
monitored by quantitative protein-bead arrays. Splenocytes from conventional IL-2(−/−) and
TAM-treated Cre+ mice resulted in undetectable IL-2 production by ELISA, so that both
strains were IL-2-deﬁcient. As monitored by ﬂow cytometry, activated CD4+ and CD8+
T cells from WT, Cre+, and Cre− mice all underwent blastogenesis, whereas far fewer
cells from conventional IL-2(−/−) mice did so. By comparison, only cells from IL-2 sufﬁcient
WT and Cre− mice switched to aerobic glycolysis as evidenced by a drop in media pH.
Blastogenesis was mirrored by BrdU incorporation and CFSE dye dilution by CD4+ and
CD8+T cells fromWT, Cre+, and Cre− mice, which were all equivalent, while proliferation
of cells from conventional IL-2(−/−) mice was compromised. Splenocytes from IL-2 deﬁ-
cient conventional IL-2(−/−) mice produced low or undetectable other γc-chain cytokines
(IL-4, IL-7, IL-9, IL-13, IL-15, and IL-21), whereas production of these γc-chain cytokines from
IL-2-deﬁcient conditional IL-2(−/−) Cre+ mice were comparable with WT and Cre− mice.
These results indicate that CD4+ and CD8+T cell blastogenesis cannot be attributable to
IL-2 alone, but a switch to aerobic glycolysis was attributable to IL-2, and proliferation after
CD3/CD28 activation is dependent on γc-chain cytokines, and not CD3/28 triggering per se.
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INTRODUCTION
With the discovery and puriﬁcation to homogeneity of the
ﬁrst leukocytotrophic hormone, interleukin-2 (IL-2; Smith et al.,
1983), and its receptor (IL-2R; Robb et al., 1981) almost 30 years
ago, deﬁnitive in vitro reductionist experiments became possible
for the ﬁrst time using puriﬁed homogeneous IL-2 and cloned
T cells (Baker et al., 1979), together with monoclonal antibod-
ies (MoAbs) reactive with both IL-2 (Smith et al., 1983) and the
IL-2 receptor (IL-2R; Leonard et al., 1982). These experiments
established that although antigen initiates T cell activation, the T
cell proliferative response is mediated by the antigen non-speciﬁc
IL-2/IL-2R interaction (Cantrell and Smith, 1984; Meuer et al.,
1984). Furthermore, in vitro differentiation of both helper and
cytolytic T lymphocytes (HTL and CTL) is also dependent on
the IL-2/IL-2R interaction (Baker et al., 1978; Seder et al., 1994).
Moreover, only four variables were found necessary for T cell pro-
liferation and differentiation: the afﬁnity of the IL-2/IL-2R inter-
action, the IL-2 concentration, the density of the IL-2Rs/cell, and
the duration of the IL-2/IL-2R interaction (Cantrell and Smith,
1984).
Based on these in vitro results, it was anticipated that profound
immunodeﬁciencywould result from thedeletionof the IL-2 genes
via homologous recombination [IL-2(−/−)]. However, the initial
experiments revealed only a moderate deﬁciency, in that the IL-
2(−/−) in vitro T cell proliferative responses to mitogenic lectins
was still 1/3 that of wild type (WT) T cells, rather than absent alto-
gether (Schorle et al., 1991). Subsequent experiments showed that
upon infectionwith lymphocytic choriomeningitis virus (LCMV),
the generation of virus-speciﬁc CTL was reduced by 60–90%
(Kundig et al., 1993; Cousens et al., 1995). However, IL-2(−/−)
animals still cleared the virus and recovered from the initial infec-
tion. Subsequent reports using LCMV infection of mixed bone
marrow chimeras of WT and IL-2Rα(−/−) mice, revealed that
primary immune responses of the IL-2Rα(−/−) T cells were
largely intact, but secondary immune responses to LCMV were
markedly deﬁcient and the generation of immunological memory
was impaired (Williams et al., 2006).
All of the experimental approaches that created an IL-2 deﬁ-
ciency during both prenatal and postnatal development eventually
led to a peculiar syndrome characterized by a paradoxical slow
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accumulation of activated T cells in both lymphoid and non-
lymphoid tissues (Sadlack et al., 1993; Horak et al., 1995; Klebb
et al., 1996). Therefore, even though these mice were immun-
odeﬁcient, as they matured they began to suffer from autoim-
mune phenomena, and they ultimately succumbed prematurely
due to disorders such as autoimmune hemolytic anemia and
inﬂammatory bowel disease (Sadlack et al., 1993). Accordingly,
to circumvent these developmental disadvantages of conventional
IL-2(−/−) mice, we sought to create mice that could be allowed to
reach adult stature in IL-2 sufﬁciency, and then to use an inducible
gene deletion system to generate IL-2 deﬁciency. By doing so, we
sought to test the null hypothesis, that acute IL-2 deﬁciency will
not compromise the in vitro proliferative response to T cell activa-
tion by anti-CD3/28. Our results, described in this report, indicate
that acute IL-2 deprivation in adult mice differs substantially from
conventional IL-2(−/−) mice when there is an IL-2 deﬁciency in
both prenatal and postnatal development, as well as adulthood.
MATERIALS AND METHODS
MICE
To circumvent the IL-2 deﬁciency T cell hyperprolifera-
tive/autoimmune syndrome that occurs when the il2 gene is
deleted conventionally, an il2 conditional (−/−) was constructed
by inGenious Targeting Laboratory, Inc., Stony Brooke, NY, as
shown in Figure 1A. The 62-bp lox P cassette was placed on
1402 bp of the il2 gene including exons I and II. The Neo cas-
sette (3′–5′ orientation) was placed between exons II and III. The
primers LAN1 and UNI are indicated, and FRT and loxP sites
are also indicated. The reverse primer A3 was used for ES cell
screening and F1 genotyping with the LAN1 Neo primer, while
the primer LOX1 was used for sequence veriﬁcation of the single
lox P site in PCR applicants from ES clones using DL1 and the Neo
primer UNI. F1 genotyping of the single Lox P site by PCR was
performed using DL1 and LOX1 primers, and the PCR products
were sequenced by LOX1.
To remove the Neo cassette, targeted C57BL/6 ES cells were
microinjected into Balb/c blastocysts. Resulting chimeras with a
high percentage of black coat color were mated to wild type (WT)
C57BL/6mice to generate F1 heterozygous offspring. F1 heterozy-
gotes were mated with FLP heterozygotes (Step 2), which were
screened for Neo deletion and the FLP transgene. Neo deleted
heterozygotes were mated with WT mice and screened for Neo
deletion and FLP transgene deletion. Homozygous Neo deleted
mice were then mated with Cre-ERT2 mice (Ruzankina et al.,
2007). Cre-ERT2 mice contain a gene encoding a fusion protein
composed of Cre recombinase and a mutant form of the estro-
gen receptor that is selectively activated only in the presence of
tamoxifen (TAM), but not estrogen. In combination with a ﬂox-
conditional allele of il2, the Cre-ERT2 line (hereafter referred to
as Cre+) provides a system to efﬁciently delete the il2 gene both
spatially and temporally in the mouse (Ruzankina et al., 2007).
The 62bp lox P cassette: (CGCGGTGGTACCATAACTTCG-
TATAGCATACATTATACGAAGTTATGAATTCGTCGCCACCG),
ﬂanked by EcoRI and KpnI sites; FRT(GAAGTTCCTATTCTCTAG
AAAGTATAGGAACTTC), and loxP (ATAACTTCGTATAATGTAT-
GCTATACGAAGTTAT) sites are indicated in Figure 1A. FLP het-
erozygotes (Jackson Lab #0033800) and Cre-ERT2 (Ruzankina
et al., 2007) were used. WT (C57BL/6; Jackson Lab #000664) and
conventional IL-2(−/−) mice (Jackson Lab #002252) were bred at
Weill CornellMedical CollegeAnimal Facility.Animal studieswere
approved by the Institutional Animal Care and Use Committee
(the IACUC).
PCR SCREENING STRATEGY
The reverse primerA3 (5′-TGGAAGGATTCACTTGCACAGTGAC-
3′)was used for ES cell screening andF1 genotypingwith the LAN1
(5′-CCAGAGGCCACTTGTGTAGC-3′) Neo primer. Primer LOX1
(5′-TGCTTGTTGAGCTTGAGGTAC-3′) was used for sequence
veriﬁcationof the single loxP site inPCRapplicants fromES clones
using DL1 (5′-ACACATACATGTGCACGCACATGC-3′) and the
Neo primer UNI (5′-AGCGCATCGCCTTCTATCGCCTTC-3′).
After FLP mating (Figure 1A, Step 2), the mice were screened for
FLP transgene by FLP1: 5′-CACTGATATTGTAAGTAGTTTGC-3′
and primer FLP2: 5′-CTAGTGCGAAGTAGTGATCAGG-3′.
TAMOXIFEN (TAM)-INDUCED il2 GENE DELETION
Cre+ and Cre− mice (Figure 1B) were allowed to reach adult
stature (6–12weeks old) then treated with TAM (MP Biochemi-
cals) solubilized at 20mg/mL in amixture of 98% corn oil (Sigma)
and 2%ethanol and delivered intomice by oral gavage (0.5μmol/g
body weight;∼4mg/200μL) once per day for 5 days, followed by
a 3-day rest. In initial screens of genomic DNA via PCR a very
faint band consistent with the 320-bp fragment of non-deleted
il2 exons I and II was detected. Therefore, rather than attempt to
quantify this residual genomic IL-2 at the DNA or RNA levels, the
efﬁciency of TAM-induced il2 gene deletion was assessed in all
mice and in all experiments by IL-2 ELISA as detailed below.
SPLENOCYTES ISOLATION, CULTURE, AND ACTIVATION
In all experiments total splenocytes from different mouse strains
were isolated and activated with soluble anti-CD3 and anti-
CD28 (both 2μg/mL, eBioscience) in complete cell culture media
(RPMI 1640 with l-glutamine (Cellgro), supplemented with
10% FBS, 100U/mL Penicillin/Streptomycin (both Gemini Bio-
Products), and 2μM 2-ME (Sigma-Aldrich). The cells (1mL,
2× 106 cells/mL) were cultured in 12-well plates (BD Labware)
in a 37˚C humidiﬁed incubator with 5% CO2.
IL-2 ELISA
Freshly isolated splenocytes were activated and cultured for 20–
24 h, when supernatants were harvested. The mouse IL-2 Quan-
tikine Immunoassay kit (R&D Systems) was used to quantify
IL-2 concentrations in cell culture supernatants following the
manufacturer’s protocol and experimental samples were com-
pared with the kit IL-2 standard. The lower limit of detection
(LLD)= 15 pg/mL= 1 pM.
BrdU INCORPORATION AND CFSE DYE DILUTION
Freshly isolated splenocytes were activated and cultured for
48 h. BrdU (BrdU Kit, BD Biosciences) was added for the last
2 h. In some experiments, splenocytes were ﬁrst labeled with
5μM 5-(and 6-) carboxyﬂuorescein diacetate succinimidyl ester
(CFSE; Molecular Probes) prior to culture, activated and cultured
for 48 h.
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FIGURE 1 | Schematic of conditional il2 gene deletion. (A) Step 1: il2
gene knock-out constructs schematic shows ﬂoxed targeted region
including exons I and II (1402 bp) and Neo cassette inserted between
exons II and III. The primers DL1, Lox1, UNI, LAN1 and A3, and FRT and
loxP sites are indicated. Step 2: il2 gene schematic after Neo cassette
deletion upon FLP mating and the primers DL1, Lox1, SG1, and A3 is
also indicated. Step 3: Schematic of il2 gene of TAM-treated Cre+
(Cre-ERT2/ﬂox-il2) mice is shown. (B) Schematics of il2 gene in the Cre−
mice before TAM treatment and the Cre+ mice upon deletion of exons I
and II by TAM.
MONOCLONAL ANTIBODIES
The following surface mAbs were used all reactive with mouse
molecules: CD4 PerCp, CD8 PE, CD8 APC (all BD Biosciences).
BrdU mAb (BrdU Kit, BD Biosciences) was used to detect BrdU
incorporation into newly synthesized DNA.
FLOW CYTOMETRY
Four-color ﬂow cytometry and standard staining protocols
were used. Single cell suspensions of splenocytes were stained
ﬁrst for surface molecules for 30min in the dark (4˚C),
then washed once with Washing Buffer (1X PBS (Cellgro)
with 0.5% FBS (Gemini Bio-Products) and 0.1% NaN3). The
cell pellet was resuspended and acquired on a FACSCalibur
ﬂow cytometer. The BD Biosciences BrdU Kit staining proto-
col was used. The data were analyzed using FlowJo software
(Tree Star), whereby the Overton cumulative histogram sub-
traction method was used to assess the percent of positive
cells.
CYTOKINE PRODUCTION
Culture supernatants were tested for cytokine production by
AssayGate (www.assaygate.com) using suspension protein arrays
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with bead-based array technology, as described previously (Paulo
et al., 2011). Thirteen cytokines (Table 1) were determined using a
custommultiplexed protein assaymethodology established upon a
Luminex Bead-based immunoassay platform. Multiple cytokines
in a single aliquot of cell culture supernatant were determined
quantitatively and simultaneouslywith aBio-Plex 200BeadReader
System. Microparticles were dyed with differing concentrations of
two ﬂuorophores to generate distinct bead sets. Each bead set
was coated with a capture antibody speciﬁc for one cytokine. The
captured cytokinewas detected using a biotinylated detection anti-
body and streptavidin–phycoerythrin (S–PE). The bead analyzer
was a dual laser, ﬂow-based, sorting and detection platform. One
laser was bead-speciﬁc and determined which cytokine was being
detected. The other laser determined themagnitude of PE-derived
signal, which was in direct proportion to the amount of cytokine
bound.
The cytokine protein concentrations of the samples were deter-
mined by a ﬁve-parameter logistic regression algorithm with
analysis of the median ﬂuorescence intensity readings of an eight-
point protein standard curve. This regression provides a larger
range of quantitation than standard linear regression analysis.
Once a regression equation was derived, the ﬂuorescence inten-
sity values of the standards were treated as unknowns, and the
concentration of each standard cytokine was calculated. A ratio of
the calculated value to the expected value of this standard was then
determined. A ratio between 70 and 130% for each of the stan-
dards indicated a goodﬁt. If the ﬂuorescence intensity values of the
samples reached a plateau, or were outside the range of standard
curves, a re-test with diluted samples was performed to ensure that
the ﬂuorescence intensity measurements of unknown samples fell
inside the range of the standard curves. Precision was evaluated
by the CV% in our assays. A CV%<10% indicates a good level of
precision. Samples were tested in duplicate. Positive and negative
controls on each bead plate allowed for assay quality assurance.
The assays were sensitive to the ﬁrst decimal in pg/mL. The LLD
for IL-2= 1.2 pg/mL= 0.08 pM,>10-fold more sensitive than the
IL-2 ELISA.
STATISTICAL ANALYSIS
One-way ANOVA was performed in the analysis of the mean dif-
ferences between the groups. A post Bonferroni comparison test
on selected groups was used to assess the level of signiﬁcance of
the mean differences between the groups, represented by asterisks
in the ﬁgures [∗ (p< 0.05); ∗∗ (p< 0.01); ∗∗∗ (p< 0.001); ∗∗∗∗
(p< 0.0001)]. Two-way ANOVA was performed in the analysis of
the mean differences from ELISA assay. p values of <0.05 were
considered statistically signiﬁcant.
RESULTS
THE EFFICIENCY OF TAM-INDUCED il2 DELETION
The most sensitive and quantitative test available to determine
the efﬁcacy of IL-2 deletion is the detection of the IL-2 pro-
tein, rather than available semi-quantitative methods that detect
genomic DNA or mRNA, in that the LLD by both IL-2 bioas-
say and ELISA is 1 pM (15 pg/mL). Also, we were most interested
in deleting IL-2 activity for our planned experiments. Therefore,
both Cre+ and Cre− mice were allowed to reach adult stature
FIGURE 2 |The efficiency ofTAM-induced il2 deletion.The twofold
dilution of [IL-2] (pM) by ELISA assay inWT (•; n = 11), conventional IL-2KO
(; n = 13), conditional IL-2(−/−) Cre+ (; n = 13), and Cre− (; n = 9) mice
(p< 0.0001). Anti-CD3/28-activated splenocytes were cultured in vitro for
20–24 h. The results are shown as Mean±SEM (vertical brackets).
between 6 and 12weeks of age, then treated with TAM for 5 days,
followed by a 3-day rest, as originally described (Ruzankina et al.,
2007). Subsequently, mice were sacriﬁced and splenocytes were
polyclonally activated in vitro via anti-CD3+ anti-CD28 for 20–
24 h, when culture supernatants from each individual mouse were
harvested and tested via ELISA for immuno-reactive IL-2 protein.
As shown in Figure 2, there was readily detectable IL-2 from both
WT (141± 14 pM) and the Cre− mice (116± 9 pM; p> 0.05).
By comparison, splenocytes from neither conventional IL-2(−/−)
nor conditional IL-2(−/−) Cre+ mice yielded detectable IL-2 by
this assay. Since the afﬁnity (K d) of the trimeric IL-2 receptor (IL-
2R) for IL-2= 10 pM, with a dose–response range between 1 and
100 pM, these results indicated that TAM treatment had rapidly
and effectively created a marked state of IL-2 deﬁciency in the
Cre+ IL-2 conditional IL-2(−/−) mice, whereas TAM treatment
of Cre− mice was not detrimental to IL-2 gene expression.
LYMPHOCYTE BLASTIC TRANSFORMATION
Lymphocyte blastic transformation and the associated switch from
oxidative phosphorylation to aerobic glycolysis with the marked
production of lactic acid are among the earliest cellular changes
attributed to mitogen or antigen-stimulated lymphocytes (Now-
ell, 1960). Thus, in our ﬁrst experiments it was of interest that the
Forward Scatter histograms (Figure 3A) and Forward Scatter/Side
Scatter dot plots (Figure 3B) from the ﬂow cytometric analyses
of splenocytes activated for 48 h with anti-CD3/28 revealed that
CD4+ T cells from the WT, Cre−, and Cre+ mice had all under-
gone a marked increase in cell size and granularity, but cells from
the conventional IL-2(−/−)mice hadnot. Themeanpercentage of
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FIGURE 3 | Lymphocyte blastic transformation in CD4T cells. (A)
Forward Scatter histograms and (B) Dot plots monitoring Side and
Forward Scatter in CD4T cells fromWT (upper left), conventional IL-2KO
(upper right), Cre− (lower left), and conditional IL-2(−/−) Cre+ (lower
right) mice and (C)The difference in Forward Scatter by CD4T cells from
WT (•; n = 8), conventional IL-2KO (; n = 8), Cre− (; n = 6), and
conditional IL-2(−/−) Cre+ (; n = 10) mice (p< 0.0001). (D) Dot plots
monitoring BrdU and Forward Scatter in CD4T cells fromWT (upper
left), conventional IL-2KO (upper right), Cre− (lower left), and conditional
IL-2(−/−) Cre+ (lower right) mice. Anti-CD3/28-activated splenocytes
were cultured for 48 h. Representative histograms and Side and Forward
Scatter dot plots (B) were chosen from 1 of 6–10 independent
experiments, while BrdU and Forward Scatter dot plots (C) were chosen
from one of ﬁve to seven independent experiments. Dotted histogram
lines represent non-activated cells. The results are shown as
Mean±SEM (vertical brackets). Asterisks represent the level of
statistical signiﬁcance.
CD4+ T cells from conventional IL-2(−/−) mice that underwent
blastic transformation was signiﬁcantly lower thanWT,Cre−, and
Cre+ (p< 0.05; Figure 3C). There were no signiﬁcant differences
in the mean percentages of increased CD4+ T cell sizes compar-
ingWT, Cre−, and Cre+ mice (Figure 3C). Moreover, when pulse
labeled with BrdU, the increase in the size of CD4+ T cells from
WT, Cre−, and conditional Cre+ IL-2(−/−) mice was coupled
with increased newDNA synthesis in contrast to the CD4+ T cells
from conventional IL-2(−/−) mice (Figure 3D).
Similar results were obtained with CD8+ T cells, although
CD8+ T cells from the conventional IL-2(−/−) mice were some-
what larger andmore granular than CD4+ T cells (Figures 4A,B).
The mean percentage of blastic CD8+ T cells from conventional
IL-2(−/−) mice was signiﬁcantly lower thanWT,Cre−, and Cre+
(p< 0.05; Figure 4C). By comparison, there were no signiﬁcant
differences in the mean percentages of blastic CD8+ T cells com-
paringWT,Cre−, andCre+mice (Figure 4C).Aswell, the increase
FIGURE 4 | Lymphocyte blastic transformation in CD8T cells. (A)
Forward Scatter histograms and (B) Dot plots monitoring Side and
Forward Scatter in CD8T cells fromWT (upper left), conventional IL-2KO
(upper right), Cre− (lower left)„ and conditional IL-2(−/−) Cre+ (lower
right) and (C)The difference in Forward Scatter by CD4T cells fromWT
(•; n = 8), conventional IL-2KO (; n = 8), Cre− (; n = 6), and
conditional IL-2(−/−) Cre+ (; n = 10) mice (p< 0.0001). (D) Dot plots
monitoring BrdU and Forward Scatter in CD8T cells fromWT (upper
left), conventional IL-2KO (upper right), Cre− (lower left), and conditional
IL-2(−/−) Cre+ (lower right) mice. Anti-CD3/28-activated splenocytes
were cultured for 48 h. Representative histograms and Side and Forward
Scatter dot plots (B) were chosen from 1 of 6–10 independent
experiments, while BrdU and Forward Scatter dot plots (C) were chosen
from 1 of 5–7 independent experiments. Light color histogram lines
represent non-activated cells. The results are shown as Mean±SEM
(vertical brackets). Asterisks represent the level of statistical
signiﬁcance.
in the size of CD8+ T cells fromWT, Cre−, and conditional Cre+
IL-2(−/−)micewas coupledwith increased newDNA synthesis in
contrast to the CD8+ T cells from conventional IL-2(−/−) mice,
although this was not as marked as the results with CD4+ T cells
(compare Figure 4D with Figure 3D).
Because of the divergence of Forward Scatter results from IL-2
deﬁcient conventional IL-2(−/−) and IL-2 deﬁcient conditional
IL-2(−/−) Cre+ mice, lymphocyte blastic transformation cannot
be attributed solely to IL-2.
Also, examination of culture media from splenocytes activated
with anti-CD3/28 and cultured for 48 h yielded the results shown
in Figure 5. The media from activated IL-2 sufﬁcientWT cells was
noticeably yellow, indicating a drop in pH, as was the media from
the IL-2 sufﬁcient Cre− cells. By comparison, themedia fromboth
activated IL-2 deﬁcient conventional IL-2(−/−) and conditional
Cre+ IL-2(−/−) cells was similar to the normal red color of the
media of the control, non-activated cells, consistent with oxidative
phosphorylation, rather than a switch to aerobic glycolysis.
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FIGURE 5 | IL-2 is necessary for aerobic glycolysis.Tissue culture media
color fromWT (upper left), conventional IL-2KO (lower left), conditional
IL-2(−/−) Cre+ (upper right), and Cre− (lower right) mice upon
anti-CD3/28-activation for 48 h. The media color of the non-activated
(control) splenocytes from different mouse strains is also shown.
Representative picture was chosen from one of ﬁve to seven independent
experiments.
Accordingly, these results indicated that even though T cells
from IL-2 deﬁcient conditional IL-2(−/−) Cre+ mice had under-
gone lymphoblastic transformation, they had not switched to
aerobic glycolysis, at least not to the extent that cells from IL-2
sufﬁcient WT and Cre− mice had.
PROLIFERATION OF ACTIVATED CD4+ T CELLS
The incorporation of BrdU into newly synthesized DNA was
monitored to assess the S-phase transition of T cells from the
four strains of mice. Splenocytes were activated for 46 h with
anti-CD3/28, then pulse labeled with BrdU for 2 h. Representa-
tive histogram plots of BrdU incorporation by CD4+ T cells are
shown in Figure 6A, and the means± SEM of the results from
repeated experiments are shown in Figure 6B. There were no
signiﬁcant differences in the mean percentages of CD4+ T cells
that incorporated BrdU comparing WT, Cre−, and Cre+ mice.
However, themean percentage of CD4+T cells from conventional
IL-2(−/−) mice that incorporated BrdU was signiﬁcantly lower
than CD4+ T cells from WT, Cre−, and Cre+ (p< 0.05). Similar
results were obtained when CFSE dye dilution wasmonitored 48 h
after activation with anti-CD3/28 as a measure of the extent of cell
division. Representative histogram plots are shown in Figure 6C,
and the means± SEM of the results from repeated experiments
are shown in Figure 6D. There were no signiﬁcant differences in
the mean percentages of CD4+ T cells that underwent dye dilu-
tion comparing WT, Cre−, and Cre+ mice. However, the mean
percentage of CD4+ T cells from conventional IL-2(−/−) mice
that diluted CFSE dye was signiﬁcantly lower thanWT, Cre−, and
Cre+ (p< 0.05).
PROLIFERATION OF ACTIVATED CD8+ T CELLS
The incorporation of BrdU into newly synthesized DNA of CD8+
cells after 46 h of culture and a 2-h BrdU pulse yielded similar
results. Representative histogram plots of BrdU incorporation are
shown in Figure 7A, and the means± SEM of the results from
repeated experiments are shown in Figure 7B. There were no
signiﬁcant differences in the mean percentages of CD8+ T cells
that incorporated BrdU comparing WT, Cre−, and Cre+ mice.
However, the mean percentage of CD8+ T cells from conven-
tional IL-2(−/−) mice that incorporated BrdU was signiﬁcantly
lower than WT, Cre−, and Cre+ (p< 0.05). Similar results were
obtained when CFSE dye dilution wasmonitored 48 h after activa-
tion with anti-CD3/28 as a measure of the extent of cell division.
Representative histogram plots are shown in Figure 7C, and the
means± SEM of the results from repeated experiments are shown
in Figure 7D. There were no signiﬁcant differences in the mean
percentages of CD8+ T cells that underwent dye dilution com-
paringWT, Cre−, and Cre+ mice. However, the mean percentage
of CD8+ T cells from conventional IL-2(−/−) mice that diluted
CFSE dye was signiﬁcantly lower than WT, Cre−, and Cre+
(p< 0.05).
CYTOKINE PRODUCTION
In view of the proliferation of both CD4+ and CD8+ T cells
from IL-2 deﬁcient conditional IL-2(−/−) Cre+ mice, which
was equivalent to T cells from both WT and Cre− mice, we
next monitored the production of multiple cytokines via protein
immunoarray. Splenocytes from each of the four mouse strains
were activated via anti-CD3/28 and supernatants were harvested
after 24 h. First, as shown in Table 1 and Figure 8, IL-2 production
byWT splenocytes yielded IL-2 concentrations equivalent to those
found by ELISA (mean 1496± 567 pg/mL= 97± 37 pM), which
would saturate high afﬁnity trimeric IL-2Rs. Also, IL-2 produc-
tion by conventional IL-2(−/−) splenocytes was undetectable, as
anticipated. Moreover, IL-2 production by IL-2 sufﬁcient Cre−
splenocytes was not signiﬁcantly different than WT IL-2 produc-
tion (p> 0.05). However, splenocytes from IL-2 deﬁcient condi-
tional IL-2(−/−) Cre+ mice produced just barely detectable IL-2
(mean 13.6± 3.9 pg/mL= 0.9± 0.2 pM;<1%ofWT), in contrast
to our IL-2 ELISA results, where IL-2 was undetectable.
Examination of the production of pro-inﬂammatory cytokines
(IL-1β, IL-6, and TNFα) yielded no differences among the four
strains of mice (Table 1). Also, IL-12 concentrations were very
low or absent in all strains. The IL-2 deﬁcient conventional IL-
2(−/−) cells produced IL-17 concentrations equivalent to theWT
and Cre− IL-2 sufﬁcient strains, but the IL-2 deﬁcient conditional
IL-2(−/−) Cre+ strain produced signiﬁcantly lower IL-17 con-
centrations than WT (p< 0.05). These results are contrary to the
dogma that IL-2 suppresses IL-17 production. By comparison,
the WT, Cre−, and IL-2 deﬁcient conditional IL-2(−/−) Cre+
strains all produced equivalent concentrations of IFNγ, but the
IL-2 deﬁcient conventional IL-2(−/−) strain produced signiﬁ-
cantly lower concentrations of IFNγ than WT, Cre−, and Cre+
(p< 0.05; Table 1).
Focusing on the other six γc-chain cytokines (Table 1), there
were signiﬁcant differences among the four strains of mice. First,
both IL-7 and IL-15 were undetectable from all strains of mice,
thereby excluding either of them as candidates that could promote
in vitro proliferation. Splenocytes fromWTmice produced readily
detectable IL-4 (Figure 9A), IL-9 (Figure 9B), IL-13 (Figure 9C),
and IL-21 (Figure 9D). By comparison to WT mice, splenocytes
from IL-2 deﬁcient conventional IL-2(−/−) mice produced very
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Table 1 | Cytokine production.
Exp# IL-2 IL-4 IL-7 IL-9 IL-13 IL-15 IL-21 IL-1β IL-6 IL-12 TNF-α IL-17 IFN-γ
WT
1 3321.4 85.3 0.7 0.0 190.5 0.0 12.2 23.3 2245.6 0.0 188.8 1149.7 14364.0
2 2227.6 32.0 0.0 0.0 191.7 0.0 63.0 187.0 5778.5 53.1 310.3 4041.3 12957.1
3 333.7 148.5 0.0 50.8 287.7 0.0 72.5 68.8 5188.3 0.0 549.8 2325.3 16376.3
4 453.6 120.6 0.0 37.7 209.0 0.1 23.0 58.3 4804.4 0.0 380.2 840.8 14299.8
5 1147.5 158.5 0.0 63.4 254.3 0.4 14.4 51.1 4597.7 0.0 680.7 2456.4 17158.5
Mean 1496.8 109.0 0.1 30.4 226.6 0.1 37.0 77.7 4522.9 10.6 421.9 2162.7 15031.2
SEM 566.8 23.1 0.1 13.0 19.1 0.1 12.8 28.3 603.7 10.6 87.1 566.4 762.2
IL-2KO
1 0.0 7.1 1.6 0.0 0.0 4.6 1.5 210.3 4093.9 0.0 178.0 470.5 437.0
2 2.1 2.0 0.2 0.0 40 0.6 25.8 90.3 1841.5 0.0 163.9 881.2 42.3
3 0.0 1.9 0.0 9.3 9.6 0.0 11.1 139.4 14887.3 0.0 638.2 2040.4 871.7
4 2.0 10.8 0.0 26.6 3.2 0.6 0.0 44.1 1407.0 0.0 420.7 234.3 274.0
5 0.0 0.8 0.0 0.0 9.6 0.0 59.3 84.2 14594.3 0.0 394.5 3614.8 520.8
Mean 0.8 4.5 0.3 7.2 5.3 1.2 19.5 113.7 7364.8 0.0 359.1 1448.2 429.1
SEM 0.5 1.9 0.3 5.2 1.9 0.9 10.9 28.5 3054.9 0.0 87.7 624.3 137.5
CRE−
1 1855.3 118.2 0.0 0.0 49.5 0.0 59.6 35.9 4542.7 23 701.3 350.2 14281.5
2 546.8 82.5 0.3 0.0 248.5 0.4 61.5 127.2 3410.1 0.0 265.2 1371.9 12913.8
3 914.2 84.8 0.0 19.4 71.0 0.0 14.0 60.3 5423.8 0.0 400.9 848.4 11976.4
4 653.4 150.5 0.0 66.2 140.5 0.7 113.4 80.1 6379.1 0.0 462.2 1107.5 12199.7
5 1244.8 120.2 0.0 35.0 117.7 0.2 149.3 67.2 5557.7 0.0 470.3 1508.8 11694.5
Mean 1042.9 111.2 0.1 24.1 125.6 0.3 79.6 74.2 5062.7 0.5 460.0 1037.4 12613.3
SEM 236.1 12.6 0.1 12.4 34.8 0.1 23.5 15.1 505.5 0.5 70.6 205.8 463.4
CRE+
1 24.2 143.6 0.0 0.0 66.9 1.6 444.2 48.4 5591.4 30.7 1095.8 930.9 14587.5
2 0.0 25.3 0.0 0.0 63.2 0.0 55.3 103.2 3771.8 14.6 250.2 791.0 12943.1
3 11.9 54.3 0.0 20.0 27.9 0.0 43.7 36.0 2784.8 0.0 290.3 268.3 11559.1
4 16.3 54.8 0.0 44.0 31.8 0.6 64.2 44.9 2857.3 0.0 410.4 187.2 13345.2
5 15.5 44.5 0.0 32.9 12.3 0.5 0.0 47.0 3830.8 0.0 326.1 166.8 11371.1
Mean 13.6 64.6 0.0 19.4 40.4 0.5 121.5 55.9 3767.6 9.1 474.6 468.8 12761.2
SEM 3.9 20.5 0.0 8.8 10.6 0.3 81.4 12.0 506.6 6.1 157.5 162.5 595.3
The concentrations (pg/mL) of 13 cytokines from WT, conventional IL-2(−/−), Cre−, and conditional IL-2(−/−) Cre+ mice. Protein-bead array was performed on super-
natants with or without anti-CD3/28-activation for 24 h. The difference between anti-CD3/28-activation and the media of the control is shown, as the values for the
non-stimulated controls were very low by comparison. The results from ﬁve individual experiments and the Mean±SEM are shown.
low concentrations of IL-4 and IL-13 (p< 0.05), but IL-9 and IL-
21 production were not signiﬁcantly different from that produced
by WT cells (p> 0.05). Moreover, the IL-4 production from IL-2
deﬁcient conventional IL-2(−/−) cells was signiﬁcantly lower than
from IL-2 deﬁcient conditional IL-2(−/−) Cre+ cells (p< 0.05),
while the IL-13, IL-9, and IL-21 production were not signiﬁcantly
different (p> 0.05).
The γc-chain cytokines produced by the IL-2 sufﬁcient Cre−
mice were not signiﬁcantly different from those produced by cells
from WT mice, except for IL-13 (p< 0.05), which was ∼ 50%
of WT production, and IL-9, which was approximately twofold
higher thanWT production (p< 0.05).
Most noteworthy were the results from the IL-2 deﬁcient con-
ditional IL-2(−/−) Cre+ mice. It is apparent that splenocytes
from these animals produced readily detectable IL-4, IL-9, IL-
13, and IL-21, in contrast to the IL-2 deﬁcient conventional
IL-2(−/−) mice.
DISCUSSION
Several of the results from these ﬁrst experiments performed with
IL-2 deﬁcient conditional IL-2(−/−)mice were unanticipated and
revealing. First, lymphocyte blastogenesis cannot be attributed to
IL-2 alone, whereas the switch from oxidative phosphorylation to
aerobic glycolysis in T cells is attributable to IL-2. Second, despite
the almost complete deﬁciency of IL-2 production by cells from
conditional IL-2(−/−) Cre+mice,DNA replication, and cell divi-
sion proceeded as well as that observed in cells from both IL-2
sufﬁcientWT and Cre− mice. Therefore, we have proved our null
hypothesis. Third, the complete absence of IL-2 in the prenatal and
postnatal development of conventional IL-2(−/−) mice results in
a deﬁciency in several γc-chain cytokines, notably IL-4, IL-9, IL-
13, and IL-21, but not in several other cytokines, e.g., IL-1β, IL-6,
and TNFα. Fourth, deﬁciencies in the capacity to produce the
other γc-chain cytokines does not occur in acutely IL-2 deﬁcient
conditional IL-2(−/−) mice.
www.frontiersin.org May 2012 | Volume 3 | Article 102 | 7
Popmihajlov et al. Conditional IL-2 gene deletion
FIGURE 6 | Proliferation of activated CD4T cells. (A) BrdU incorporation in
CD4T cells fromWT (upper left), conventional IL-2KO (upper right), Cre−
(lower left), and conditional IL-2(−/−) Cre+ (lower right) mice. (B)The
difference in BrdU incorporation by CD4T cells fromWT (•; n = 6),
conventional IL-2KO (; n = 6), Cre− (; n = 5), and conditional IL-2(−/−) Cre+
(; n = 7) mice (p = 0.0041). (C) CD4T cell proliferation monitored by the
CFSE dilution fromWT (upper left), conventional IL-2KO (upper right), Cre−
(lower left), and conditional IL-2(−/−) Cre+ (lower right) mice. (D)The
difference in CD4T cell proliferation fromWT (•; n = 6), conventional IL-2KO
(; n = 6), Cre− (; n = 5), and conditional IL-2(−/−) Cre+ (; n = 7) mice
(p< 0.0001). Anti-CD3/28-activated splenocytes were cultured for 48 h.
Representative histograms were chosen from one of ﬁve to seven
independent experiments. The percentages are also shown for each
histogram. Shaded histograms represent non-activated cells. The results are
shown as Mean±SEM (vertical brackets). Asterisks represent the level of
statistical signiﬁcance.
It is worthy of emphasis that absolute IL-2 deﬁciency did
not result from TAM-induced IL-2 gene deletion, in that by the
very sensitive Multiplex Protein Array method (LLD= 0.08 pM),
a mean of 0.87± 0.25 pM (SEM) of IL-2 protein (n = 5) could
be detected in the 20- to 24-h culture supernatants, whereas the
conventional IL-2(−/−) cells did not yield detectable IL-2 pro-
tein. Given these low IL-2 concentrations detected after 24 h of
culture, the question arises as to whether the results observed
after 48 h of culture could be due to these low IL-2 concentra-
tions. For example, if a low fraction of cells from conditional
Cre+ IL-2(−/−) mice produce IL-2, could local autocrine or
paracrine IL-2 supplied to neighboring cells result in equivalent
results between WT and conditional Cre+ IL-2(−/−) mice? As
detailed in the very ﬁrst report of IL-2 receptor binding from both
equilibrium and kinetic binding experiments (Robb et al., 1981),
and then discussed thoroughly in reviews (Smith, 1988a,b, 1989),
the IL-2/IL-2R interaction obeys the Law of Mass Action, and
the equilibrium dissociation constant (K d) for the high afﬁnity
trimeric IL-2R is 10 pM. Therefore, an IL-2 concentration<1 pM,
would be expected to lead to <10% occupancy of the IL-2Rs
expressed by an individual cell. Since IL-2 activity and the fraction
of responding cells is dependent upon the afﬁnity of the IL-2/IL-
2R interaction,which dictates the IL-2 concentrations necessary to
bind IL-2Rs, as well as the IL-2R density/cell, and the duration of
the IL-2/IL-2R interaction (Cantrell and Smith, 1984), only those
cells with the highest IL-2R densities would be expected to bind
and respond to <1 pM IL-2, and thus the fraction of these cells
within the total responding population would be correspondingly
small. Thus, the response to IL-2 is linear, and at the single cell
level the response is quantal anddependent upon the four variables
mentioned (Smith, 2006, 2010). Consequently, as discussed below,
<1 pM IL-2 produced during the ﬁrst 24 h cannot account for the
results obtained after 48 h of culture, in that the whole population
of cells from conditional Cre+ IL-2(−/−) mice was equivalent to
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FIGURE 7 | Proliferation of activated CD8T cells. (A) BrdU incorporation in
CD8T cells fromWT (upper left), conventional IL-2KO (upper right), Cre−
(lower left), and conditional IL-2(−/−) Cre+ (lower right) mice. (B)The
difference in BrdU incorporation by CD8T cells fromWT (•; n = 6),
conventional IL-2KO (; n = 6), Cre− (; n = 5), and conditional IL-2(−/−) Cre+
(; n = 7) mice (p< 0.0001). (C) CD8T cell proliferation monitored by the
CFSE dilution fromWT (upper left), conventional IL-2KO (upper right), Cre−
(lower left), and conditional IL-2(−/−) Cre+ (lower right) mice. (D)The
difference in CD8T cells proliferation fromWT (•; n = 6), conventional IL-2KO
(; n = 6), Cre− (; n = 5), and conditional IL-2(−/−) Cre+ (; n = 7) mice
(p< 0.0001). Anti-CD3/28-activated splenocytes were cultured for 48 h.
Representative histograms were chosen from one of ﬁve to seven
independent experiments. Shaded histograms represent non-activated cells.
The percentages are also shown for each histogram. The results are shown as
Mean±SEM (vertical brackets). Asterisks represent the level of statistical
signiﬁcance.
the populations observed for the WT and Cre− mice. Also, any
IL-2 molecules non-speciﬁcally adsorbed to the cell surface (i.e.,
on non-receptor proteins) would be miniscule compared with the
molecules present in the very low concentrations present (<1 pM).
Moreover, any of these surface molecules would be incapable of
signaling. Accordingly, alternative explanations are necessary to
explain our results. In this regard, future experiments should nec-
essarily focus on the fraction of cells expressing IL-2Rs, as well as
the cell type. It is also evident that it is possible, and even probable,
that a very small fraction of cells (<1% of WT) are responsible for
the production of IL-2 by the Cre+ cells. By monitoring the IL-2
molecule at the single cell level, future experiments will determine
the proportion and phenotype of IL-2 producing and respond-
ing cells. These approaches should be much more accurate as well
as biologically signiﬁcant than employing a surrogate ﬂuorescent
marker gene product, such as Yellow Fluorescent Protein.
Lymphocyte blastic transformationwasﬁrst described in exper-
iments with the mitogenic lectin phytohemagglutinin (PHA),
which was found to activate and transform human lympho-
cytes into lymphoblasts, resembling leukemia cells (Nowell, 1960).
Nowell remarked at the time that it was curious that the change in
cellular morphology proceeded only after several days of culture
and not immediately or soon after addition of PHA to the cul-
tures. To account for the delay, he postulated that perhaps the
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cells released some soluble product into the media, which was
actually responsible for the phenomenon, rather than the PHA
per se. Five years later, two simultaneous reports described the
ﬁrst soluble mitogenic activity in leukocyte conditioned media,
which they termed “Blastogenic Factor” (Gordon and MacLean,
1965; Kasakura and Lowenstein, 1965). Over the ensuing decade,
numerous reports identiﬁedT cellmitogenic activities in leukocyte
FIGURE 8 | IL-2 cytokine production.The difference in [IL-2] (pg/ml) from
WT, conventional IL-2KO, Cre−, and conditional IL-2(−/−) Cre+ mice upon
anti-CD3/28-activation for 24 h (p = 0.0061). The Mean±SEM (vertical
brackets) results from 5 individual experiments are shown. Asterisks
represent the level of statistical signiﬁcance.
conditioned media. Once the IL-2 receptor (IL-2R; Robb et al.,
1981) and the TCR complex (Meuer et al., 1983) were identiﬁed,
and it was understood that activation of the TCR leads to the
production of IL-2 and the expression of the IL-2R (Cantrell and
Smith, 1984; Meuer et al., 1984), it was possible for the ﬁrst time
to approach the experimental question as to whether the TCR or
the IL-2R was responsible for the marked morphological cellular
changes of blastic transformation. Experiments performed with
normal human lymphocytes yielded the clear-cut result that the
IL-2/IL-2R interaction,but not the TCR, is responsible not only for
lymphocyte blastic transformation, but also progression through
the G1 phase of the cell cycle and the transition to DNA synthesis
and replication (Stern and Smith, 1986).
More recent experiments by Cantrell’s group revealed that
IL-2 and IL-15 are equivalent and potent mitogens for antigen-
stimulatedCD8+Tcells,but IL-2 stimulates blastogenesiswhereas
IL-15 does not (Cornish et al., 2006). Furthermore, they found that
IL-2 promotes twice the rate of amino acid uptake, amino acid
transporter expression and protein synthesis compared with IL-
15. These experiments showed for the ﬁrst time that blastogenesis
is not a prerequisite for T cell cycle progression and DNA replica-
tion. Now, our experiments reveal that IL-2 deﬁcient conditional
IL-2(−/−) Cre+ cells undergo blastogenesis and proliferate just
as well as IL-2 sufﬁcient WT and Cre− cells, but do not appear to
switch to aerobic glycolysis and produce large amounts of lactic
acid. Therefore, these results indicate that this fundamental cel-
lular metabolic switch to aerobic glycolysis (Vander Heiden et al.,
FIGURE 9 | IL-4, IL-9, IL-13, and IL-21 cytokine production.The difference in
(A) [IL-4] (pg/ml; p = 0.001), (B) [IL-9] (p< 0.0001), (C) [IL-13] (p< 0.0001), and
(D) [IL-21] (p = 0.3717) fromWT, conventional IL-2KO, Cre−, and conditional
IL-2(−/−) Cre+ mice upon anti-CD3/28-activation for 24 h. The Mean±SEM
(vertical brackets) results from ﬁve individual experiments are shown.
Asterisks represent the level of statistical signiﬁcance.
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2009; Finlay and Cantrell, 2011), which is usually associated with
T cell proliferation, depends upon IL-2 and is not mediated by the
TCR or the other γc-chain cytokines. It is also noteworthy that
the very low IL-2 concentrations produced by conditional Cre+
IL-2(−/−) cells were not sufﬁcient to cause a metabolic switch in
the blastoid cells that proliferated. Obviously, these initial obser-
vations based upon media pH will now need follow-up with more
detailed and sophisticated metabolic measurements.
Our results showing that DNA replication monitored by BrdU
incorporation and cell division monitored by CFSE dye dilution
were not signiﬁcantly different when comparing the cell popula-
tions fromIL-2deﬁcient conditional IL-2(−/−) and IL-2 sufﬁcient
WT and Cre− mice was unanticipated. However, these results
contrasted with those obtained with cells from IL-2 deﬁcient con-
ventional IL-2(−/−) mice, which were obviously deﬁcient in both
DNA replication and cell division. In this regard, it is noteworthy
that our results with IL-2 deﬁcient conventional IL-2(−/−) cells
are consistent with the deﬁcient tritiated thymidine incorporation
reported in the very ﬁrst mitogen experiments conducted with
cells from these animals (Schorle et al., 1991). Therefore, another
cause of the proliferation by the conditional Cre+ IL-2(−/−) cells,
besides IL-2, was sought to explain our results.
It was also unanticipated to ﬁnd that IL-2 deﬁcient conven-
tional IL-2(−/−) cells failed to produce normal concentrations of
other γc-chain cytokines, notably IL-4 and IL-13. This result, cou-
pled with adequate production of these γc-chain cytokines by cells
from the IL-2 deﬁcient conditional IL-2(−/−) Cre+ mice, offers
a reasonable explanation for the deﬁcient proliferative responses
in cells from the conventional IL-2(−/−) mice compared with the
conditional IL-2(−/−) mice. This interpretation gains consider-
able weight in light of the complete lack of proliferative responses
by anti-CD3/28 stimulated T cells from STAT5a/b(−/−) mice
that express only ∼ 1% of STAT5 protein compared with WT
mice, even when supplemented with IL-2 (Moriggl et al., 1999a,b).
Together with our results, these data are consistent with the inter-
pretation that neither “signal 1” (TCR) nor “signal 2” (CD28) can
promote progression through the G1 phase of the cell cycle into
the S-phase. Instead, a “signal 3” is needed, which is supplied via
γc-chain cytokines that activate the phosphorylation of STAT5.
In support of this interpretation, several reports have detailed
that IL-2-signaled STAT5 activation of cyclin D gene expression
is necessary for G1 progression and S-phase transition whereas
signals emanating from the TCR and/or CD28 do not (Turner,
1993; Beadling et al., 1994, 1996; Martino et al., 2001; Moon et al.,
2004). Therefore, the molecular contributions of the three signals
to T cell activation and proliferation are now understood.
It is noteworthy that experiments using antibodies reactivewith
IL-2 is another approach that has been tried to explore the role of
IL-2 in T cell responses both in vitro and in vivo. In this regard, it
has not escaped our attention that cytokine-speciﬁcMoAbs should
be useful to further examine the role of each cytokine in vitro.
However, antibodies that neutralize IL-2 activity in vitro, such as
DMS-1 (Smith et al., 1983) and S4B6 (Zurawski et al., 1986), have
been found to actually stimulate IL-2 effects in vivo because of a
protein carrier effect, which complicates interpretations as to the
IL-2 role (Courtney et al., 1994; Boyman et al., 2006).
Accordingly, our newly created IL-2 deﬁcient IL-2(−/−) mice
offer a new tool to further dissect the role of IL-2 and the other
γc-chain cytokines in the generation of adaptive T cell immune
responses. In particular, whether IL-2 deﬁcient conditional (−/−)
Cre+ mice will be found to have defective primary vs. secondary
immune responses, and whether they will lack T cell memory in
response to a secondary antigenic challenge must await additional
experimentation.
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